Annual Report 2020
Department of Psycho-Oncology Service
Asao Ogawa, Masanori Enokido, Yusei Iwata, Daisuke Fujisawa, Mayumi Takahashi
Introduction
The aim of the Department of Psycho-oncology Service is to develop mind-centered interventions to restore, maintain, and improve the quality of life of patients and their families throughout cancer treatment, and in the end-of-life period. Our Service has focused on developing effective interventions for delirium, dementia, and depression in cancer patients as well as on determining the mechanism underlying the relationship between cancer and the mind through a combination of neuropsychiatric, psychosocial, and behavioral sciences.
Especially, increases in the number of individuals diagnosed with cancer each year, due in large part to the growth of the aging population, as well as improving survival rates have resulted in an ever-increasing number of elderly cancer patients with deteriorating cognitive functions. Therefore, we conduct research on the development and validation of geriatric assessment such as minicog and comprehensive geriatric assessment (CGA), etc., and the evaluation of effectiveness about multidisciplinary interventions among hospitalized cancer patients with delirium or cognitive function disorder, including mild cognitive impairment.
The Team and What We Do
The Department of Psycho-Oncology Service is composed of three attending psychiatrists and three clinical psychologists. The clinical activity includes psychiatric consultation involving comprehensive assessment and addressing the psychiatric problems of cancer patients. The patients are either self-referred or referred by their oncologist in charge. The consultation data are shown in Tables 1, 2. Psychiatric diagnosis is based on the DSM-5 (Diagnostic and Statistical Manual of Mental Disorder, 5th edition) criteria. Consultation data also include individuals who are family members of cancer patients.
Table 1. Supportive care team consultation data (n=1032; April 2020 to March 2021)
Table 2. Psycho-oncology outpatient consultation data (n=699; April 2020 to March 2021)
A conference with the Supportive Care Team is held every Wednesday, and a multicenter joint clinical teleconference involving six cancer center hospitals and three university hospitals is held every Thursday.
Research activities
1. A multi-center, cluster randomized controlled study comparing usual care and multidisciplinary interventions such as DELirium Team Approach-program (DELTA program) to prevent the development and severity of delirium among hospitalized cancer patients (Research and Development grants for cancer at the Japan Agency for Medical Research and Development)
Delirium, defined as an acute disorder of attention and global cognitive function, is a common, serious, and potentially preventable source of morbidity and mortality for hospitalized elderly people. Primary prevention, i.e., preventing delirium before it develops, is the most effective strategy for reducing delirium. We have reported the effectiveness of multidisciplinary intervention to prevent the development and severity of delirium among hospitalized patients designed by a multi-center, cluster randomized controlled study.
2. Development of a dementia care support system utilizing artificial intelligence that proposes prevention and early detection of BPSD and appropriate care (Health Labour Sciences Research Grant)
With the growing number of elderly people, the prevalence of dementia with physical and mental conditions in acute care hospitals has increased. The purpose of this study is to disseminate appropriate dementia care in acute care hospitals in Japan through the development of a support system that utilizes artificial intelligence for physical care and dementia care for people with dementia.
We have reported the educational effects of dementia care for acute care hospital nurses and plan to evaluate the clinical effects.
List of papers published in 2020
Journal
1. Nakazawa Y, Takeuchi E, Miyashita M, Sato K, Ogawa A, Kinoshita H, Kizawa Y, Morita T, Kato M. A Population-Based Mortality Follow-Back Survey Evaluating Good Death for Cancer and Noncancer Patients: A Randomized Feasibility Study. J Pain Symptom Manage, 61:42-53.e2, 2021
2. Shikimoto R, Tamura N, Irie S, Iwashita S, Mimura M, Fujisawa D. Group cognitive behavioural therapy for family caregivers of people with dementia: A single-arm pilot study. Psychogeriatrics, 21:134-136, 2021
3. Kitakata H, Kohno T, Kohsaka S, Fujisawa D, Nakano N, Shiraishi Y, Katsumata Y, Yuasa S, Fukuda K. Prognostic Understanding and Preference for the Communication Process with Physicians in Hospitalized Heart Failure Patients. J Card Fail, 27:318-326, 2021
4. Kosugi K, Nishiguchi Y, Miura T, Fujisawa D, Kawaguchi T, Izumi K, Takehana J, Uehara Y, Usui Y, Terada T, Inoue Y, Natsume M, Yajima MY, Watanabe YS, Okizaki A, Matsushima E, Matsumoto Y. Association Between Loneliness and the Frequency of Using Online Peer Support Groups Among Cancer Patients With Minor Children: A Cross-Sectional Web-Based Study. J Pain Symptom Manage, 61:955-962, 2021
5. Takeuchi E, Fujisawa D, Miyawaki R, Yako-Suketomo H, Oka K, Mimura M, Takahashi M. Cross-cultural validation of the Cancer Stigma Scale in the general Japanese population. Palliat Support Care, 19:75-81, 2021
6. Fujisawa D, Umemura S, Okizaki A, Satomi E, Yamaguchi T, Miyaji T, Mashiko T, Kobayashi N, Kinoshita H, Mori M, Morita T, Uchitomi Y, Goto K, Ohe Y, Matsumoto Y. Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised controlled trial. BMJ Open, 10:e037759, 2020
7. Maeda I, Ogawa A, Yoshiuchi K, Akechi T, Morita T, Oyamada S, Yamaguchi T, Imai K, Sakashita A, Matsumoto Y, Uemura K, Nakahara R, Iwase S. Safety and effectiveness of antipsychotic medication for delirium in patients with advanced cancer: A large-scale multicenter prospective observational study in real-world palliative care settings. Gen Hosp Psychiatry, 67:35-41, 2020
8. Matsuda Y, Tanimukai H, Inoue S, Inada S, Sugano K, Hasuo H, Yoshimura M, Wada S, Dotani C, Adachi H, Okamoto Y, Takeuchi M, Fujisawa D, Kako J, Sasaki C, Kishi Y, Akizuki N, Inagaki M, Uchitomi Y, Matsushima E, Okuyama T. JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Jpn J Clin Oncol, 50:586-593, 2020
9. Nakanishi M, Ogawa A, Nishida A. Availability of home palliative care services and dying at home in conditions needing palliative care: A population-based death certificate study. Palliat Med, 34:504-512, 2020
10. Matsuda Y, Maeda I, Morita T, Yamauchi T, Sakashita A, Watanabe H, Kaneishi K, Amano K, Iwase S, Ogawa A, Yoshiuchi K. Reversibility of delirium in Ill-hospitalized cancer patients: Does underlying etiology matter? Cancer Med, 9:19-26, 2020
11. Katayama K, Ishikawa D, Miyagi Y, Takemiya S, Okamoto N, Ogawa A. Qualitative analysis of cancer telephone consultations: Differences in the counseling needs of Japanese men and women. Patient Educ Couns, 2020
12. Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol, 25:1-42, 2020
13. Aoyama M, Sakaguchi Y, Fujisawa D, Morita T, Ogawa A, Kizawa Y, Tsuneto S, Shima Y, Miyashita M. Insomnia and changes in alcohol consumption: Relation between possible complicated grief and depression among bereaved family caregivers. J Affect Disord, 275:1-6, 2020
14. Hashimoto N, Takahashi K, Fujisawa D, Aoyama K, Nakagawa A, Okamura N, Toyomaki A, Oka M, Takanobu K, Okubo R, Narita H, Kitagawa K, Udo N, Maeda T, Watanabe S, Oyanagi Y, Miyazaki A, Ito K, Kusumi I. A pilot validation study of the Japanese translation of the Positive and Negative Syndrome Scale (PANSS). Asian J Psychiatr, 54:102210, 2020
15. Tamura N, Park S, Sato Y, Takita Y, Morishita J, Ninomiya A, Kosugi T, Sado M, Mimura M, Fujisawa D. Study protocol for evaluating the efficacy of Mindfulness for health professionals building resilience and compassion program (MaHALO program): a randomized, waiting-list controlled trial. The Journal of Psychosocial Oncology Research and Practice, 2:e22, 2020
16. Park S, Sato Y, Takita Y, Tamura N, Ninomiya A, Kosugi T, Sado M, Nakagawa A, Takahashi M, Hayashida T, Fujisawa D. Mindfulness-Based Cognitive Therapy for Psychological Distress, Fear of Cancer Recurrence, Fatigue, Spiritual Well-Being, and Quality of Life in Patients With Breast Cancer-A Randomized Controlled Trial. J Pain Symptom Manage, 60:381-389, 2020
17. Sado M, Kosugi T, Ninomiya A, Nagaoka M, Park S, Fujisawa D, Shirahase J, Mimura M. Mindfulness-Based Cognitive Therapy for Improving Subjective Well-Being Among Healthy Individuals: Protocol for a Randomized Controlled Trial. JMIR Res Protoc, 9:e15892, 2020
18. Kubo H, Urata H, Sakai M, Nonaka S, Saito K, Tateno M, Kobara K, Hashimoto N, Fujisawa D, Suzuki Y, Otsuka K, Kamimae H, Muto Y, Usami T, Honda Y, Kishimoto J, Kuroki T, Kanba S, Kato TA. Development of 5-day hikikomori intervention program for family members: A single-arm pilot trial. Heliyon, 6:e03011, 2020
19. Ninomiya A, Sado M, Park S, Fujisawa D, Kosugi T, Nakagawa A, Shirahase J, Mimura M. Effectiveness of mindfulness-based cognitive therapy in patients with anxiety disorders in secondary-care settings: A randomized controlled trial. Psychiatry Clin Neurosci, 74:132-139, 2020